I was hoping to stage a set of back to back homeruns with these two. From the way the CEO's of both were talking, Exclixis was going to be bought out in short order. Was hoping the funds from this would then be used to exercise my MNKD 2013/14 option that were to be in the money due to pending partnership. Wait and see I guess.
Not sure whether I came to following MNKD or EXEL first, but know one lead me to the other and plan to ride both to the finish. Haven't picked a third bio yet to go for the trifector, but am tapped out for additonal funds at this point.
GLTA,
OOG